205 related articles for article (PubMed ID: 19520127)
1. In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia.
Maisetta G; Mangoni ML; Esin S; Pichierri G; Capria AL; Brancatisano FL; Di Luca M; Barnini S; Barra D; Campa M; Batoni G
Peptides; 2009 Sep; 30(9):1622-6. PubMed ID: 19520127
[TBL] [Abstract][Full Text] [Related]
2. Esculentin-1b(1-18)--a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli.
Marcellini L; Borro M; Gentile G; Rinaldi AC; Stella L; Aimola P; Barra D; Mangoni ML
FEBS J; 2009 Oct; 276(19):5647-64. PubMed ID: 19725877
[TBL] [Abstract][Full Text] [Related]
3. In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia.
Pankey GA; Ashcraft DS
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):297-300. PubMed ID: 20542209
[TBL] [Abstract][Full Text] [Related]
4. Functional characterisation of the 1-18 fragment of esculentin-1b, an antimicrobial peptide from Rana esculenta.
Mangoni ML; Fiocco D; Mignogna G; Barra D; Simmaco M
Peptides; 2003 Nov; 24(11):1771-7. PubMed ID: 15019209
[TBL] [Abstract][Full Text] [Related]
5. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
Cirioni O; Giacometti A; Kamysz W; Silvestri C; Riva A; Della Vittoria A; Abbruzzetti A; Lukasiak J; Scalise G
Peptides; 2007 Apr; 28(4):747-51. PubMed ID: 17331619
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
Güzel CB; Gerçeker AA
Chemotherapy; 2008; 54(2):147-51. PubMed ID: 18322363
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia.
Zelenitsky SA; Iacovides H; Ariano RE; Harding GK
Diagn Microbiol Infect Dis; 2005 Jan; 51(1):39-43. PubMed ID: 15629227
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia.
Giacometti A; Cirioni O; Del Prete MS; Barchiesi F; Fortuna M; Drenaggi D; Scalise G
Antimicrob Agents Chemother; 2000 Jun; 44(6):1716-9. PubMed ID: 10817738
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia.
Gordon NC; Wareham DW
Int J Antimicrob Agents; 2010 Aug; 36(2):129-31. PubMed ID: 20472404
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains.
Mangoni ML; Maisetta G; Di Luca M; Gaddi LM; Esin S; Florio W; Brancatisano FL; Barra D; Campa M; Batoni G
Antimicrob Agents Chemother; 2008 Jan; 52(1):85-91. PubMed ID: 17954700
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
14. Esculentin 1-21: a linear antimicrobial peptide from frog skin with inhibitory effect on bovine mastitis-causing bacteria.
Islas-Rodrìguez AE; Marcellini L; Orioni B; Barra D; Stella L; Mangoni ML
J Pept Sci; 2009 Sep; 15(9):607-14. PubMed ID: 19507197
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Neisseria gonorrhoeae to antimicrobial peptides from amphibian skin, dermaseptin, and derivatives.
Zairi A; Tangy F; Ducos-Galand M; Alonso JM; Hani K
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):319-24. PubMed ID: 17254733
[TBL] [Abstract][Full Text] [Related]
16. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.
Entenza JM; Moreillon P
Int J Antimicrob Agents; 2009 Jul; 34(1):8.e1-9. PubMed ID: 19162449
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
Giacometti A; Cirioni O; Kamysz W; Silvestri C; Del Prete MS; Licci A; D'Amato G; Lukasiak J; Scalise G
J Antimicrob Chemother; 2005 Aug; 56(2):410-2. PubMed ID: 15983026
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
[TBL] [Abstract][Full Text] [Related]
20. [Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].
Tao CM; Li XC; Lü XJ; Li P; Yu RJ; Gao YY; Chen HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):91-3. PubMed ID: 14981826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
